Another good takeaway from the recent C3 Summit was about the practice of embedded interviews for gathering qualitative data regarding a patient’s experience of participating in a clinical trial.

Alongside the data collected against the desired endpoints and outcomes for the trial, this kind of information is useful for understanding people’s experience of their condition, and elements of trial participation that may affect a trial’s effectiveness.

The interviews can be performed at various stages – such as prior to trial participation, at regular intervals while in the trial, and an exit interview regarding the overall experience the patient had.

The FDA is moving toward guidance that incorporates ongoing interviews as a standard part of the trial process, and the industry as a whole is paying more attention to the patient experience while taking part.

Which can only be a good thing for helping improve recruitment and retention rates for current and future trials.

You may also like

FemHealth Integrates 18 March 2025 - Part Two
A few weeks ago, I attended the excellent FemHealth Investigates event in Manchester. At the end of one of the sessions, the panelists requested that we all commit to do something to help ...
FemHealth Integrates Event 18 March 2025 - Part One
A couple of days ago, I attended the FemHealth Integrates event in Manchester – which was excellent.  I’ve always found it strange that over the last few years the clinical trials industry ...
Thoughts on the Final Day of the 2025 SCOPE Summit
It’s the fourth and final day of the 2025 SCOPE Summit in Orlando. From reading the many LinkedIn posts, and being in touch with people who are attending, I can tell it’s gone great. As ...